title: Chronic myeloid leukemia and risk of second malignancy in two eras of treatment.
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Northwestern Feinberg University School of Medicine, Chicago, IL 60611, USA. brady-stein@northwestern.edu
authors.forename: Brady L
authors.initials: BL
authors.lastname: Stein
mesh_terms: D001549:Benzamides; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D010879:Piperazines / Q000009:adverse effects*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate